Tenecteplase: a review

特奈特普酶 医学 组织纤溶酶原激活剂 纤溶剂 心肌梗塞 溶栓药 丸(消化) 耐受性 纤溶酶原激活剂 重症监护医学 溶栓 药理学 瑞替普酶 内科学 不利影响
作者
Liya Davydov,Judy W.M. Cheng
出处
期刊:Clinical Therapeutics [Elsevier BV]
卷期号:23 (7): 982-997 被引量:87
标识
DOI:10.1016/s0149-2918(01)80086-2
摘要

Certain shortcomings of the available thrombolytic agents have prompted the search for a more fibrin specific fibrinolytic agent with a longer half-life. Such properties would allow bolus administration, possibly leading to faster reperfusion of occluded arteries.This article focuses on the new thrombolytic agent tenecteplase, reviewing its mechanism of action, pharmacokinetic characteristics, clinical efficacy, tolerability, and potential for drug interactions in the management of acute myocardial infarction.English-language articles for inclusion in this review were identified through searches of MEDLINE, EMBASE, and International Pharmaceutical Abstracts from 1966 to April 2001. The search terms used included tenecteplase, myocardial infarction, TNK, and TNK-tPA. Abstracts from recent conferences and symposia were also consulted.Tenecteplase is a variant of the native tissue-type plasminogen activator (tPA) molecule that has 14-fold greater fibrin specificity than alteplase, a longer half-life, slower plasma clearance, and 80-fold greater resistance to inhibition by plasminogen activator inhibitor type 1. Its half-life of approximately 18 minutes allows single-bolus administration. In comparative clinical trials, tenecteplase was found to have equivalent efficacy to recombinant tPA (alteplase). The rate of intracranial hemorrhage with tenecteplase was similar to that with alteplase, and tenecteplase was associated with fewer noncerebral complications and less need for blood transfusions.Tenecteplase appears to be as effective and well tolerated as alteplase in the management of acute myocardial infarction and offers the convenience of single-bolus administration.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Hello应助子非鱼采纳,获得10
1秒前
2秒前
4秒前
mzhmhy发布了新的文献求助10
6秒前
李健的粉丝团团长应助ASA采纳,获得30
7秒前
Choi完成签到,获得积分0
7秒前
无辜如容发布了新的文献求助10
7秒前
123完成签到,获得积分10
8秒前
9秒前
单耳兔完成签到 ,获得积分10
9秒前
潇湘雪月发布了新的文献求助10
9秒前
故意的靳完成签到,获得积分10
11秒前
mzhmhy完成签到,获得积分10
11秒前
bkagyin应助wish采纳,获得10
15秒前
Afaq发布了新的文献求助10
15秒前
果粒多发布了新的文献求助10
16秒前
16秒前
无辜如容完成签到,获得积分10
17秒前
17秒前
20秒前
21秒前
ASA发布了新的文献求助30
21秒前
22秒前
情怀应助tingting9采纳,获得10
23秒前
FXQ123_范发布了新的文献求助10
23秒前
sun完成签到,获得积分20
23秒前
25秒前
彭于晏应助wldsd采纳,获得30
25秒前
量子星尘发布了新的文献求助10
25秒前
26秒前
26秒前
高一淼发布了新的文献求助10
27秒前
明道若昧完成签到,获得积分10
27秒前
上官若男应助mk采纳,获得10
28秒前
wish完成签到,获得积分10
30秒前
wish发布了新的文献求助10
32秒前
稍等一下完成签到 ,获得积分10
33秒前
momo发布了新的文献求助10
33秒前
35秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989263
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253814
捐赠科研通 3270066
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136